March figures show decline in New Zealand’s manufacturing sector
New Zealand's manufacturing sector contracted in March and remains well below the long-term average signalling challenges for the sector, according to the latest BNZ – BusinessNZ Performance of Manufacturing Index (PMI).
Austal reports strong growth, eyes further expansion in 2025
Austal Limited has reported strong financial growth in the first half of the 2025 financial year, with earnings exceeding expectations and a record order book supporting future expansion.
Markforged reveals 10% increase in revenue amid strong manufacturing resiliency
American additive manufacturing company Markforged has reported that its first quarter results revenue increased by 10 per cent, to $24.1 million (AUD 36 million) from $21.9 million (AUD 32.7 million) in the same period of the prior year.
Fonterra announces lift in Farmgate Milk Price and FY25 earnings guidance
Fonterra Co-operative Group Ltd has revealed a 50 cent increase in its 2024/25 forecast Farmgate Milk Price midpoint, now sitting at $9.00 per kgMS.
Novonix unveils results of Hatch’s engineering study on proprietary zero-waste cathode synthesis process
Novonix, an ASX-listed manufacturer of battery materials and technology, has announced the results of the Hatch engineering report on its proprietary cathode synthesis process.
Manufacturing growth slows in February as S&P Global PMI signals softer expansion
Australia’s manufacturing sector remained in expansion in February, but growth lost momentum as new orders slowed and output edged into contraction, according to the latest Purchasing Managers’ Index (PMI®) data released by S&P Global.
Additive manufacturing set to drive $110B market by 2034, reports AM Research
Additive Manufacturing Research (AM Research) has released an updated analysis projecting that additive manufacturing (AM) applications will reach $24.5 billion in market impact by 2025 and expand to $110 billion by 2034.
Immuron prepares for diarrhoea-focused clinical trial as US FDA lifts clinical hold
Immuron, an Australia-based biopharmaceutical company, is slated to move forward with the clinical evaluation of a new oral therapeutic targeting Campylobacter and Enterotoxigenic Escherichia coli (ETEC) following approval from the US Food and Drug Administration (FDA).
4DMedical receives gov’t funding to further develop lung scanner tech
Australian respiratory imaging tech company 4DMedical Limited has secured $1.1 million in funding from the Clinical Translation and Commercialisation Medtech (CTCM) program, an initiative of the Medical Research Future Fund delivered by MTPConnect.
Archer Materials moves quantum tech from lab to wafer-scale manufacturing
Archer Materials is transitioning its qubit development program from laboratory-scale work to wafer-scale manufacturing using semiconductor industry-standard processes.


























